We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.11B
AUM Growth
+$52.8M
Cap. Flow
-$12.7M
Cap. Flow %
-1.14%
Top 10 Hldgs %
19.77%
Holding
2,152
New
581
Increased
526
Reduced
430
Closed
561

Sector Composition

Rank Sector Weight
1 Technology 16.1%
2 Healthcare 13.61%
3 Communication Services 11.16%
4 Consumer Discretionary 6.46%
5 Real Estate 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALDR
301
DELISTED
Alder Biopharmaceuticals
ALDR
$672K 0.06%
54,819
-31,873
-37% -$332K
NTAP icon
302
NetApp
NTAP
$35.9B
$667K 0.06%
15,243
+15,193
+30,386% +$627K
TWM icon
303
ProShares UltraShort Russell2000
TWM
$42.8M
$664K 0.06%
1,775
-125
-7% -$52.3K
WM icon
304
Waste Management
WM
$90.5B
$662K 0.06%
8,463
+2,969
+54% +$226K
DISCK
305
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$662K 0.06%
32,674
+24,604
+305% +$552K
CLVS
306
DELISTED
Clovis Oncology, Inc.
CLVS
$656K 0.06%
7,967
-9,769
-55% -$774K
XLU icon
307
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
$653K 0.06%
+24,600
New +$660K
AMJ
308
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$653K 0.06%
23,140
-380
-2% -$10.9K
AMH icon
309
American Homes 4 Rent
AMH
$12.4B
$651K 0.06%
29,965
-39,348
-57% -$883K
AMC icon
310
AMC Entertainment Holdings
AMC
$2.54B
$648K 0.06%
4,406
+4,108
+1,379% +$686K
FTI icon
311
TechnipFMC
FTI
$27.1B
$636K 0.06%
30,635
+29,286
+2,171% +$588K
QTS
312
DELISTED
QTS REALTY TRUST, INC.
QTS
$628K 0.06%
12,000
-34,811
-74% -$1.85M
CORT icon
313
Corcept Therapeutics
CORT
$12.2B
$624K 0.06%
32,349
+19,020
+143% +$284K
VNQ icon
314
PUT
Vanguard Real Estate ETF
VNQ
$39.3B
$623K 0.06%
7,500
-500
-6% -$41.8K
FRED
315
DELISTED
Fred's Inc
FRED
$623K 0.06%
+96,804
New +$634K
REXR icon
316
Rexford Industrial Realty
REXR
$8.4B
$616K 0.06%
21,527
+18,827
+697% +$540K
GEF icon
317
Greif
GEF
$4.93B
$615K 0.06%
10,502
+2,900
+38% +$165K
HRTX icon
318
Heron Therapeutics
HRTX
$96.8M
$614K 0.06%
+38,043
New +$597K
CC icon
319
Chemours
CC
$2.57B
$613K 0.06%
12,110
+3,410
+39% +$161K
SYT
320
DELISTED
Syngenta Ag
SYT
$611K 0.06%
+6,640
New +$612K
NVS icon
321
Novartis
NVS
$292B
$605K 0.05%
7,867
+7,777
+8,641% +$587K
LMNX
322
DELISTED
Luminex Corp
LMNX
$593K 0.05%
29,178
+23,531
+417% +$469K
MYOK
323
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$593K 0.05%
13,832
-11,068
-44% -$353K
VWTR
324
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$592K 0.05%
35,454
+9,855
+38% +$164K
ALR
325
CALL
DELISTED
Alere Inc
ALR
$586K 0.05%
+11,500
New +$574K

Similar funds

Prelude Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Prelude Capital Management held 2,152 positions worth $1.11B, up 5% from $1.06B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Prelude Capital Management's Q3 2017 filing shows 581 new, 526 increased, 430 reduced and 561 closed positions. Its largest new stake was Rockwell Collins: 63,879 shares worth $8.35M. The largest sale was Mobileye N.V., an estimated $25.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Communication Services.

  • Prelude Capital Management's largest Q3 2017 buy was Rockwell Collins: 63,879 shares worth $8.35M.
  • Prelude Capital Management added most to Calpine Corporation in Q3 2017, an estimated $12.6M increase.
  • Prelude Capital Management's biggest Q3 2017 reduction was Gray Television, cutting an estimated $14.3M.
  • Prelude Capital Management fully exited Mobileye N.V. in Q3 2017, selling an estimated $25.8M.
  • Prelude Capital Management's ten largest holdings make up 20% of its $1.11B portfolio in Q3 2017.
  • Prelude Capital Management opened 581 new positions and closed 561 in Q3 2017.
  • Prelude Capital Management's portfolio value rose 5% quarter-over-quarter to $1.11B.

Based on Prelude Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.